Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2020
Sep. 30, 2020
Current Assets    
Cash and cash equivalents $ 265.8 $ 302.2
Trade receivables, net 307.0 279.5
Receivables from long-term manufacturing contracts 158.9 138.1
Inventories, net 388.5 385.4
Prepaid expenses and other current assets 85.1 83.2
Current assets held for sale 150.0 181.3
Total current assets 1,355.3 1,369.7
Property, plant, and equipment, net 307.6 314.2
Operating lease right-of-use assets 153.0 154.4
Intangible assets, net 965.9 960.7
Goodwill 1,185.9 1,137.8
Other long-term assets 47.6 50.6
Total Assets 4,015.3 3,987.4
Current Liabilities    
Trade accounts payable 274.2 271.6
Liabilities from long-term manufacturing contracts and advances 214.1 189.1
Current portion of long-term debt 28.1 36.3
Accrued compensation 80.8 96.1
Current liabilities held for sale 23.6 32.5
Other current liabilities 254.7 226.5
Total current liabilities 875.5 852.1
Long-term debt 1,368.3 1,516.3
Accrued pension and postretirement healthcare 171.8 166.8
Operating lease liabilities 119.9 120.9
Deferred Income Tax Liabilities, Net 204.7 185.8
Other long-term liabilities 68.8 66.1
Total Liabilities 2,809.0 2,908.0
Commitments and contingencies (Note 15)
SHAREHOLDERS’ EQUITY    
Common stock, no par value (75.8 and 75.8 shares issued, 75.1 and 74.8 shares outstanding) 0.0 0.0
Additional paid-in capital 717.2 723.6
Retained earnings 541.4 481.4
Treasury stock (0.7 and 1.0 shares) (32.0) (43.2)
Accumulated other comprehensive loss (40.7) (102.8)
Hillenbrand Shareholders’ Equity 1,185.9 1,059.0
Noncontrolling interests 20.4 20.4
Total Shareholders’ Equity 1,206.3 1,079.4
Total Liabilities and Shareholders’ Equity $ 4,015.3 $ 3,987.4